您当前所在的位置:首页 > 产品中心 > 产品详细信息
155141-29-0 分子结构
点击图片或这里关闭

(2Z)-but-2-enedioic acid; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione

ChemBase编号:73051
分子式:C22H23N3O7S
平均质量:473.49892
单一同位素质量:473.12567109
SMILES和InChIs

SMILES:
c1cccc(n1)N(CCOc1ccc(cc1)CC1C(=O)NC(=O)S1)C.C(=O)(/C=C\C(=O)O)O
Canonical SMILES:
O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C.OC(=O)/C=C\C(=O)O
InChI:
InChI=1S/C18H19N3O3S.C4H4O4/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;5-3(6)1-2-4(7)8/h2-9,15H,10-12H2,1H3,(H,20,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1-
InChIKey:
SUFUKZSWUHZXAV-BTJKTKAUSA-N

引用这个纪录

CBID:73051 http://www.chembase.cn/molecule-73051.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
(2Z)-but-2-enedioic acid; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione
IUPAC传统名
maleic acid; rosiglitazone
别名
Rosiglitazone maleate
5-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleate
5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione (2Z)-2-Butenedioate
Avandia
BRL-49653c
Rosiglitazone Maleate
CAS号
155141-29-0
PubChem SID
162037971
PubChem CID
5281055

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
PubChem 5281055 external link

理论计算性质

理论计算性质

JChem
Acid pKa 6.844312  质子受体 5 
质子供体 1  LogD (pH = 5.5) 2.151827 
LogD (pH = 7.4) 2.2077625  Log P 2.446348 
摩尔折射率 97.7899 cm3 极化性 37.403675 Å3
极化表面积 71.53 Å2 可自由旋转的化学键 9 
里宾斯基五规则 true 

分子性质

分子性质

理化性质 安全信息 产品相关信息 生物活性(PubChem)
溶解度
DMSO expand 查看数据来源
Methanol expand 查看数据来源
Water (pH 2.3) expand 查看数据来源
外观
White To Off-White Solid expand 查看数据来源
熔点
122-123°C expand 查看数据来源
保存条件
-20°C expand 查看数据来源
-20°C Freezer expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
成盐信息
maleate expand 查看数据来源
Maleate expand 查看数据来源
质检报告
下载链接 expand 查看数据来源

详细说明

详细说明

Selleck Chemicals Selleck Chemicals TRC TRC
Selleck Chemicals -  S2505 external link
Research Area: Cardiovascular Disease
Biological Activity:
Rosiglitazone maleate (Avandia) is an anti-diabetic agent in the thiazolidinedione class of agents. Rosiglitazone maleate (Avandia) acts primarily by increasing insulin sensitivity. Rosiglitazone maleate (Avandia) improves glycemic control while reducing circulating insulin levels. Rosiglitazone is a member of the thiazolidinedione class of agents. They reduce glucose, fatty acid, and insulin blood concentrations. They work by binding to the peroxisome proliferator-activated receptors (PPARs). Thiazolidinediones enter the cell, bind to the nuclear receptors, and affect the expression of DNA. Rosiglitazone maleate (Avandia) also appears to have an anti-inflammatory effect in addition to its effect on insulin resistance. [1]
Toronto Research Chemicals -  R693500 external link
Insulin sensitizer; binds to peroxisome proliferator activated receptor gamma (PPAR- γ).

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • http://en.wikipedia.org/wiki/Rosiglitazone
  • Cantello, B.C.C., et al.: J. Med. Chem., 37, 3977 (1994)
  • Oakes, N.D., et al.: Diabetes, 43, 1203 (1994)
  • Balton, G.C., et al.: Xenobiotica, 26, 627 (1994)
  • Barman, J.A., et al.: Drugs, 57, 921 (1994)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle